COVID-19 in Patients with Behçet’s disease

Behçet’s disease patients are usually on long-term therapy with colchicine, TNF inhibitors, or glucocorticoids; a recent study aimed to understand the prevalence of COVID-19-related clinical outcomes in Behçet’s disease patients treated with these therapies.

Read More »
Join Our Community!Stay Informed. Stay Hopeful.

Sign up for periodic emails with resources, insights, and updates on autoimmune disease and living with chronic illness.